Portal de Periódicos da CAPES

Liver transplantation in metabolic diseases: Current status

2002; Wiley; Volume: 6; Issue: 5 Linguagem: Inglês

10.1034/j.1399-3046.2002.2e031.x

1399-3046

M. Burdelski,

Pediatric Hepatobiliary Diseases and Treatments

Pediatric TransplantationVolume 6, Issue 5 p. 361-363 Liver transplantation in metabolic diseases: Current status M. Burdelski, M. Burdelski University Hospital Hamburg – Eppendorf Department of Pediatrics Pediatric Gastroenterology and Hepatology Martinistr. 52 D-20246 Hamburg Germany Tel.: 49-40-42803-4629 Fax: 49-40-42803-5311 [email protected]Search for more papers by this author M. Burdelski, M. Burdelski University Hospital Hamburg – Eppendorf Department of Pediatrics Pediatric Gastroenterology and Hepatology Martinistr. 52 D-20246 Hamburg Germany Tel.: 49-40-42803-4629 Fax: 49-40-42803-5311 [email protected]Search for more papers by this author First published: 17 September 2008 https://doi.org/10.1034/j.1399-3046.2002.2e031.xCitations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Kelly DA. Current results and evolving indications for pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1998: 27: 214–221. 10.1097/00005176-199808000-00017 CASPubMedWeb of Science®Google Scholar 2 Burdelsk M, Nolkemper D, Ganschow R, et al. Liver transplantation in children. Long-term outcome and quality of life. Eur J Pediatr 1999: 158 (Suppl. 2): S34–S42. 10.1007/PL00014322 PubMedWeb of Science®Google Scholar 3 Ganschow R, Broering DC, Stuerenburg I, Hellwege HH, Rogiers X. First experience with basiliximab in pediatric liver graft recipients. Pediatr Transpl 2001: 5: 353–358. 10.1034/j.1399-3046.2001.00020.x CASPubMedWeb of Science®Google Scholar 4 Ganschow R, Nolkemper D, Helmke K, et al. Intensive care management after pediatric liver transplantation: A single center experience. Pediatr Transpl 2000: 4: 272–279. 10.1034/j.1399-3046.2000.00127.x Google Scholar 5 Burdelski M, Rodeck B, Latta A. Treatment of inherited metabolic disorders by liver transplantation. J Inherit Metab Dis 1991: 14: 604–618. 10.1007/BF01797930 CASPubMedWeb of Science®Google Scholar 6 Mohan N, McKiernan P, Preece MA, et al. Indications and outcome of liver transplantation in tyrosinemia type 1. Eur J Pediatr 1999: 158 (Suppl. 2): S49–S54. 10.1007/PL00014321 PubMedWeb of Science®Google Scholar 7 Sokal EM, Sokol R, Cornier V, et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999: 158 (Suppl. 2): S81–S84. 10.1007/PL00014328 PubMedWeb of Science®Google Scholar 8 Sigurdsson L, Reyes J, Kocoshis SA, et al. Neonatal hemochromatosis: Outcome of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998: 26: 85–89. 10.1097/00005176-199801000-00015 CASPubMedWeb of Science®Google Scholar 9 Sternlieb J. Perspectives on Wilson's disease. Hepatology 1990: 12: 1234–1239. 10.1002/hep.1840120526 CASPubMedWeb of Science®Google Scholar 10 Kelly DA. Editorial. Liver transplantation: To do or not to do. Pediatr Transpl 2000: 4: 170–172. 10.1034/j.1399-3046.2000.00125.x CASPubMedGoogle Scholar 11 Nemeth A. Liver transplantation in α1-antitrypsin deficiency. Eur J Pediatr 1999: 154 (Suppl. 2): S85–S88. 10.1007/PL00014329 PubMedWeb of Science®Google Scholar 12 Matern D, Starzl TE, Arnaout W, et al. Liver transplantation for glycogen storage disease types I, III and IV. Eur J Pediatr 1999: 158 (Suppl. 2): S43–S48. 10.1007/PL00014320 PubMedWeb of Science®Google Scholar 13 Sally R, O'Grady J, Williams R. Transplantation in primary biliary cirrhosis. J Gastroenterol Hepatol 1991: 6: 558–562. 10.1111/j.1440-1746.1991.tb00909.x PubMedWeb of Science®Google Scholar 14 Lewis JH, Bontempo FA, Spiro JA, Ragni MV, Starzl TE. Liver transplantation in a hemophiliac. N Engl J Med 1985: 312: 1189–1190. 10.1056/NEJM198505023121812 CASPubMedWeb of Science®Google Scholar 15 Saudubray JM, Touati G, Delonlay P, et al. Liver transplantation in urea cycle disorders. Eur J Pediatr 1999: 158 (Suppl. 2): S55–S59. 10.1007/PL00014323 PubMedWeb of Science®Google Scholar 16 Saudubray JM, Touati G, Delonlay P, et al. Liver transplantation in propionic acidemia. Eur J Pediatr 1999: 158 (Suppl. 2): S65–S70. 10.1007/PL00014325 PubMedWeb of Science®Google Scholar 17 Hoff W, Van't McKiernan P, Surtees RAH, Leonard JV. Liver transplantation for methylmalonic acidemia. Eur J Pediatr 1999: 158 (Suppl. 2): S70–S74. 10.1007/PL00014326 PubMedWeb of Science®Google Scholar 18 Wendel U, Saudubray JM, Bodner A, Schadewaldt P. Liver transplantation in maple syrup urine disease. Eur J Pediatr 1999: 158 (Suppl. 2): S60–S64. 10.1007/PL00014324 PubMedWeb of Science®Google Scholar 19 Jansen PLM. Diagnosis and management of Crigler–Najjar syndrome. Eur J Pediatr 1999: 158 (Suppl. 2): S89–S94. 10.1007/PL00014330 PubMedWeb of Science®Google Scholar 20 Cochat P, Saulier JM, Nogueira PL, et al. Combined liver–kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999: 158 (Suppl. 2): S75–S80. 10.1007/PL00014327 PubMedWeb of Science®Google Scholar 21 Nolkemper D, Kemper MJ, Burdelski M, et al. Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transpl 2000: 4: 177–181. 10.1034/j.1399-3046.2000.00107.x CASPubMedGoogle Scholar 22 Leumann E, Hoppe B. Editorial: Pre-emptive liver transplantation in primary hyperoxaluria type 1: a controversial issue. Pediatr Transpl 2000: 4: 1611–1614. 10.1034/j.1399-3046.2000.00119.x Google Scholar 23 Holme E, Lindquist S. Diagnosis and management of tyrosinemia type 1. Curr Opin Pediatr 1995: 7: 723–726. Google Scholar 24 Alshak NS, Cocjiin J, Poduta L, et al. Hepatocellular carcinoma in glycogen storage disease type IV. Arch Pathol Lab Med 1994: 118: 88–91. CASPubMedWeb of Science®Google Scholar 25 Coire JC, Qizilbash AH, Castelli MF. Hepatic adenoma in type I glycogen storage disease. Arch Pathol Lab Med 1987: 111: 166–169. PubMedWeb of Science®Google Scholar 26 Govindarajan S, Ashcavai M, Peters RL. α1-antitrypsin phenotypes in hepatocellular carcinoma. Hepatology 1981: 1: 628–631. 10.1002/hep.1840010611 CASPubMedGoogle Scholar 27 Siersema PD, Ten Kate FJW, Mulder PGH, Wilson JHP. Hepatocellular carcinoma in porphyria cutanea tarda: Frequency and factors related to its occurrence. Liver 1992: 12: 56–61. 10.1111/j.1600-0676.1992.tb00557.x CASPubMedWeb of Science®Google Scholar 28 Polio J, Enriquez RE, Chow A, Wood WM, Herbury CE. Hepatocellular carcinoma in Wilson's disease: Case report and review of the literature. J Clin Gastroenterol 1989: 11: 220–224. 10.1097/00004836-198904000-00022 PubMedWeb of Science®Google Scholar 29 Niederau C, Fischer R, Pürschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996: 110: 1107–1119. 10.1053/gast.1996.v110.pm8613000 CASPubMedWeb of Science®Google Scholar 30 Kayler LK, Merion RM, Lee S, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transpl 2002: 6: 295–300. 10.1034/j.1399-3046.2002.02009.x PubMedWeb of Science®Google Scholar 31 Couetil JP, Soubrane O, Houssin DP, et al. Combined heart–lung–liver, double–lung–liver and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997: 10: 33–39. 10.1111/j.1432-2277.1997.tb00533.x PubMedWeb of Science®Google Scholar Citing Literature Volume6, Issue5October 2002Pages 361-363 ReferencesRelatedInformation